Although shares have retreated from their all-time high, those who bought shares one year ago are still looking at growth in ...

In conjunction with its better-than-expected sales growth in the second quarter, Tempus AI raised its sales outlook for this ...

Yahoo Finance anchor Julie Hyman tracks Friday's top moving stocks and biggest market stories in this Market Minute. Gold ...

Shares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing ...

TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.

Tempus AI (NASDAQ:TEM) stock sees a 9% pre-market gain as the company raises its 2025 revenue outlook amid strong Q2 ...

Analysts expect the Chicago, Illinois-based company to report a quarterly loss at 25 cents per share, versus a year-ago loss ...

Shares of Tempus AI climbed after the company narrowed its net loss and logged higher-than-expected revenue in the second quarter, boosted by what Chief Executive Eric Lefkofsky called a significant ...

Tempus AI (NASDAQ:TEM) surged 9% in premarket trading on Friday after the genetic testing company posted a ...

The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) jumped 0.4% and 0.6%, respectively. Tempus, a ...

Tempus Ai (NASDAQ: TEM) stock is seeing an explosive valuation surge in Tuesday's trading thanks to a pair of catalysts. The healthcare software company's share price was up 35.8% as of 3:15 p.m ...

Tempus AI delivered adjusted EBITDA of -$21.8 million in the third quarter, which was a $14.4 million year-over-year improvement and also a significant improvement quarter over quarter.